Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase Journal Article


Authors: Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J.
Article Title: Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
Abstract: The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous Leukemia (CML), A small-molecule inhibitor of Abl (STI-571) is effective in the treatment of CML. We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571. Critic:al to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally Located "activation Loop" is not phosphorylated. The conformation of this Loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases, These results suggest that compounds that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.
Keywords: domain; specificity; growth; crystal-structure; complex; c-abl; insulin-receptor
Journal Title: Science
Volume: 289
Issue: 5486
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2000-09-15
Start Page: 1938
End Page: 1942
Language: English
ACCESSION: WOS:000089355800047
DOI: 10.1126/science.289.5486.1938
PROVIDER: wos
PUBMED: 10988075
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Bornmann
    112 Bornmann
  2. Bayard Clarkson
    220 Clarkson